SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20FR12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0001144204-05-024363
Filing Date
2005-08-10
Accepted
2005-08-09 17:32:20
Documents
15

Document Format Files

Seq Description Document Type Size
1 v022798_20fr12ga.htm 20FR12G/A 2602728
2 v022798_ex1.htm EX-1 463403
3 v022798_ex2-1.htm EX-2.1 291030
4 v022798_ex4-16.htm EX-4.16 22417
5 v022798_ex4-17.htm EX-4.17 180946
6 v022798_ex4-18.htm EX-4.18 107778
7 v022798_ex4-19.htm EX-4.19 58876
8 v022798_ex4-20.htm EX-4.20 41954
9 GRAPHIC logox1x1.jpg GRAPHIC 12456
10 v022798_ex4-21.htm EX-4.21 30423
11 GRAPHIC logox2x1.jpg GRAPHIC 3208
12 v022798_ex4-22.htm EX-4.22 24731
13 v022798_ex4-23.htm EX-4.23 28373
14 v022798_ex4-24.htm EX-4.24 60950
15 filename15.htm CORRESP 65373
  Complete submission text file 0001144204-05-024363.txt   4002195
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 20FR12G/A | Act: 34 | File No.: 000-51310 | Film No.: 051011191
SIC: 2834 Pharmaceutical Preparations